GlassScriptPhysician profile
Stacia N Shea
NPI 1548397243
$3,063.08
in general payments reported to CMS, 2019-2025
40 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $95.00 · 2023: $386 · 2024: $788 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.99 |
| Education | $103.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $376.86 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Astrazeneca Pharmaceuticals LP | $272.88 | 2023-2025 | Enhertu, Tagrisso, Lynparza |
| Pfizer INC. | $261.31 | 2024-2025 | |
| Janssen Biotech, INC. | $250.92 | 2021-2025 | Erleada, Darzalex, Talvey |
| Celgene Corporation | $202.30 | 2021-2025 | Reblozyl, Pomalyst |
| Karyopharm Therapeutics INC. | $144.07 | 2023-2025 | Xpovio |
| Novartis Pharmaceuticals Corporation | $110.90 | 2023-2025 | |
| Glaxosmithkline, LLC. | $102.98 | 2024-2025 | Jemperli, Ojjaara, Blenrep |
| E.R. Squibb & Sons, L.L.C. | $89.11 | 2025 | Opdualag, Opdivo |
| Eisai INC. | $86.93 | 2025 | |
| Abbvie INC. | $72.10 | 2024-2025 | |
| Deciphera Pharmaceuticals INC. | $70.86 | 2025 | Qinlock, Romvimza |
| Merck Sharp & Dohme LLC | $65.54 | 2025 | Keytruda, Welireg |
| Adc Therapeutics America, INC. | $64.56 | 2024-2025 | |
| Exelixis INC. | $64.07 | 2023-2025 | Cabometyx |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacia Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.